FDA takes first step in possible reversal of ban on some peptides The Washington Post Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Ohio Med Spas: Peptide Do's and Do Not's